TY  - GEN 
AU  - Iñiguez Romo, Andres
AU  - Chevalier, B.
AU  - Richardt, G.
AU  - Neylon, A.
AU  - Jiménez Díaz, Victor Alfonso
AU  - Kornowski, R.
AU  - Carrie, D.
AU  - Moreno, R.
AU  - Barbato, E.
AU  - Serra-Peñaranda, A.
AU  - Guiducci, V.
AU  - Valdés-Chávarri, M.
AU  - Yajima, J.
AU  - Wijns, W.
AU  - Saito, S.
PY  - 2020
SN  - 1522-1946
UR  - http://hdl.handle.net/20.500.11940/16816
AB  - OBJECTIVES: To assess the long-term safety and efficacy of a sirolimus-eluting stent with bioresorbable polymer (BP-SES; Ultimaster), in comparison to a benchmark everolimus-eluting, permanent polymer stent (PP-EES; Xience), in a prespecified subgroup...
KW  - Risk Factors
KW  - Single-Blind Method
KW  - Middle Aged
KW  - Coronary Stenosis
KW  - Prosthesis Design
KW  - Polymers
KW  - Percutaneous Coronary Intervention
KW  - Humans
KW  - Treatment Outcome
KW  - Time Factors
KW  - Republic of Korea
KW  - Sirolimus
KW  - Coronary Artery Disease
KW  - Prospective Studies
KW  - Cardiovascular Agents
KW  - Aged
TI  - Comparison of long-term clinical outcomes in multivessel coronary artery disease patients treated either with bioresoarbable polymer sirolimus-eluting stent or permanent polymer everolimus-eluting stent: 5-year results of the CENTURY II randomized clinical trial
DO  - 10.1002/ccd.28224
KW  - CHUVI
VL  - 95
ER  -